Acute Lymphoblastic Leukaemia Cancer Acute Lymphoblastic Leukaemia
Conditions
Interventions
Continuing chemotherapy/unrelated donor BMT
Sponsors
Medical Research Council (MRC) (UK)
Eligibility
Inclusion criteria
Inclusion criteria: They are children under 15 years at original diagnosis and treated on UKALL trials or pilot studies with first relapse less than 4 years from the start of treatment of ALL at any site and no suitable related bone marrow treatment (BMT) donor is available
Exclusion criteria
Exclusion criteria: 1. They are multiply relapsed patients 2. They have a prior history of toxicity or organ damage such that completion of the protocol is felt unlikely at the outset 3. They have had an isolated CNS or testicular relapse more than 6 months off treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival, disease free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed